Fuzhou Nanxia Technology Co.,Ltd. – Trademark Portfolio

Entity Type: 99

Fuzhou Nanxia Technology Co.,Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include POHYPYZ. The owner is based in Fuzhou, Fujian.

Office 53, 15F, Building 1, Xiangkai Liantian Plaza, No. 111, Dongfeng Road, Gushan Town, Jin'an District,

Fuzhou, Fujian 350000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

POHYPYZ
POHYPYZ
Registered 2025

Trademark Classifications

Fuzhou Nanxia Technology Co.,Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Fuzhou Nanxia Technology Co.,Ltd. have?

Fuzhou Nanxia Technology Co.,Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fuzhou Nanxia Technology Co.,Ltd. file in?

Fuzhou Nanxia Technology Co.,Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Fuzhou Nanxia Technology Co.,Ltd.'s most well-known trademarks?

Fuzhou Nanxia Technology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as POHYPYZ. These are among 1 currently registered trademark in the portfolio.

What is Fuzhou Nanxia Technology Co.,Ltd.'s trademark registration success rate?

Fuzhou Nanxia Technology Co.,Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.